SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

AGUIAR, Ernestina Silva de et al. GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening. Rev. bras. epidemiol. [online]. 2012, vol.15, n.2, pp. 246-255. ISSN 1415-790X.  http://dx.doi.org/10.1590/S1415-790X2012000200002.

    2. Câncer no Brasil - Dados dos registros de base populacional. volume IV; 2010. [ Links ]

    3. Lima-Costa MF, Matos DL. Prevalence and factors associated with mammograms in the 50-69-year age group: a study based on the Brazilian National Household Sample Survey (PNAD-2003) Cad Saude Publica 2007; 23: 1665-73. [ Links ]

    4. Park SK, Kang D, Noh DY, Lee KM, Kim SU, Choi JY, et al. Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk. Breast Cancer Res Treat 2003; 78: 89-96. [ Links ]

    5. Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF, et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomar Prev 1999; 8: 843-54. [ Links ]

    6. Norppa H. Genetic susceptibility, biomarkers response, and cancer. Mutat Res 2003; 544: 339-48. [ Links ]

    7. Miller PD, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, et al. Combination of the variant genotype of GSTP1, GSTM1 and, p53 are associated with an increased lung cancer risk. Cancer Res 2002; 62: 2819-23. [ Links ]

    8. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Med 1995; 37: 37-41. [ Links ]

    9. Zheng W, Wen WQ , Gustafson DR , Gross M , Cerhan JR, Folsom AR. GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat 2002; 74: 9-16. [ Links ]

    10. Lancaster JM, Berhuck A, Carney ME, Wiseman R, Taylor JA. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer 1998; 78: 227-78. [ Links ]

    11. Rossit ARB, Cabral IR, Conforti-Froes NDT. Avaliação das frequências alélicas de genes do biometabolismo em uma população brasileira. Genet Mol Biol 1999; 22(Suppl). [ Links ]

    12. Strange RC, Fryer AA. The glutathione S-tranferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999; 148: 231-49. [ Links ]

    13. Fryer AA, Bianco A, Hepple M, Peter WJ, Strange RC, Spiteri MA. Polymorphism at the Glutathione S-transferase GSTP1 Locus. Am J Respir Crit Care Med 2000; 161: 1437-42. [ Links ]

    14. Giacomazzi J, Aguiar E, Palmero EI, Schmidt AV, Skonieski G, Duarte Filho D, et al. Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density. Braz J Med Biol Res 2011; 44: 291-6. [ Links ]

    15. Gail MH, Brinton LA, Byar DP, Sylvan BC. Schairer GC, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1998; 81: 1879-86. [ Links ]

    16. American College of Radiology. Illustrated breast imaging reporting and data system (BIRADS). 3th ed. Reston: American College of Radiology; 1998. [ Links ]

    17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215. [ Links ]

    18. Gaspar PA, Moreira J, Kvitko K, Torres MR, Moreira A and Weimer TA. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: Do they indicate susceptibility to chronic obstructive pulmonary disease and non small- cell lung cancer. Genet Mol Biol 2004; 27: 133-8. [ Links ]

    19. Abramson JH. WINPEPI (PEPI-for-Windows): Computer programs for epidemiologists. Epidemiol Perspect Innov 2004; 1(6): 1-10. [ Links ]

    20. Kvitko K, Gaspar PA, Torres MR, Hutz MH. CYP1A1, GSTM1, GSTT1 and GSTP1 polymorphisms in an Afro-Brazilian group. Genet Mol Biol 2006; 29: 613-16 [ Links ]

    21. Morais LMTS, Filho CC, Lourenço GJ, Shinzato JY, Zeferino LC, Lima CSP, et al. Características Mamográficas do Câncer de Mama Associadas aos Polimorfismos GSTM1 E GSTT1, Rev Assoc Méd Bras 2008; 54 (1): 61-6. [ Links ]

    22. Gattás GJF, Kato M, Soares-Vieira JA, Siraque MS, Kohler P, Gomes L, et al. Ethnicity and glutatione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population. Braz J Med Biol Res 2004; 37: 451-8. [ Links ]

    23. Rossini A, Rapozo DCM, Amorim LMF, Macedo JMB, Medina R, Neto JFN, et al. Frequencies of GSTM1, GSTT1 and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 2002; 1: 233-40. [ Links ]

    24. Van Der Hel OL, Bueno-De-Mesquita HB, Van Gils CH, Roest M, Slothouber B, et al. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk. Cancer Causes Control 2005; 16: 675-81. [ Links ]

    25. Milikan R, Pittman G, Tse C, Savitz DA, Newman B, Bell D. Glutathione S-transferase M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 567-73. [ Links ]

    26. Samson M, Swaminathan R, Rama R, Sridevi V, Nancy KN, et al. Role of GSTM1 (Null/Present), GSTP1 Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India. Asian Pac J Cancer Prev 2007; 8: 253-7. [ Links ]

    27. Gudmundsdottir K, Tryggvadottir L, and Eyfjord JE. GSTM1, GSTT1, and GSTP1 Genotypes in Relation to Breast Cancer Risk and Frequency of Mutations in the p53 Gene. Cancer Epidemiol Biomarkers Prev 2001; 10: 1169-73. [ Links ]

    28. Egan KM, Kai Q, Shu XO, Jin F, Zhu TL, Dai Q, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 197-204. [ Links ]

    29. Curran, JE, Weinstein SR and Griffiths LR. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett 2000; 153: 113-20. [ Links ]

    30. Reyes VB. Estimativa de risco de câncer de mama, segundo o modelo de GAIL, em uma população submetida a rastreamento mamográfico em Porto Alegre [dissertação de mestrado]. Rio Grande do Sul: Universidade Federal do Rio Grande do Sul; 2009. Available in http://hdl.handle.net/10183/16768. [ Links ]

    31. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in White women with a model that includes mammographic density. J Natl Cancer Inst 2006, 98: 1215-26. [ Links ]

    32. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006; 98: 1204-14. [ Links ]

    33. Tyrer J, Duffy SW, Cuzick J.A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 15(23): 1111-30. [ Links ]

    34. Gail MH. Value of Adding Single-Nucleotide Polymorphism Genotypes to a Breast Cancer Risk Model. J Natl Cancer Inst 2009; 101: 959-963. [ Links ]

    35. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008; 100: 1037-41. [ Links ]

    36. Amorim LMF, Rossini A, Mendonça GAS, Lotsch PF, Simão TA, Gallo CVM, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett 2002; 181: 179-86. [ Links ]

    37. Ambrosone CB, Coles BF, Freudenheim JL, Shields PG. Glutathione S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J Nutr 1999; S129: 565-68. [ Links ]

    38. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer risk and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998; 58: 65-70. [ Links ]

    39. Maugard CM, Charrier J, Bignon Y-J. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. Chem Biol Interact 1998; 111: 365-75. [ Links ]

    40. Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, et al. Combined COMT and GST genotypes and hormone replacement therapy associate breast cancer risk. Pharmacogenetics 2002; 12: 67-72. [ Links ]